Chronic pain clinical trials in North York, Ontario
Part of chronic pain trials in Ontario.
4
Trials
1
Recruiting or not yet
4
Trial sites
Trials with a site in North York
4 trials, recruiting first
| Phase | ||||
|---|---|---|---|---|
| Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis NCT07178951 | Recruiting | Not applicable | FUSMobile Inc. | 2026-09-09 |
| Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) NCT04874038 | Active, not recruiting | Phase 3 | University Health Network, Toronto | 2021-09-22 |
| A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain NCT01060254 | Terminated | Phase 2 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-04-06 |
| Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" NCT00139776 | Completed | Phase 4 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-07 |
Facilities listed in the registry
- Pfizer Investigational Site (1 trial site)
- North York General Hospital (1 trial site)
- Unika Medical Centre (1 trial site)
Facility names are as entered by study registrants. This is not a clinic directory.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.